Published online before print December 9, 2004, doi: 10.1161/01.ATV.0000153046.59370.13
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Transient Role for CD1d-Restricted Natural Killer T Cells in the Formation of Atherosclerotic Lesions
From the Gladstone Institute of Cardiovascular Disease (A.M.A., I.F.C.) and the Department of Medicine and Cardiovascular Research Institute (H.A.C., I.F.C.), University of California, San Francisco.
Correspondence to Israel F. Charo, MD, PhD, Gladstone Institute of Cardiovascular Disease, PO Box 419100, San Francisco, CA 94141-9100. E-mail icharo{at}gladstone.ucsf.edu
Objective— CD1d-restricted natural killer T (NKT) cells are reported to play a proatherogenic role in the development of atherosclerosis. However, the contribution of NKT cells to mature lesion formation and the effector mechanisms through which they act are unknown.
Methods and Results— We measured lesion size in CD1d-null (CD1d–/–) mice on the low-density lipoprotein (LDL) receptor–deficient (LDLR–/–) genetic background after 4, 8, and 12 weeks of feeding on a Western diet. Lesions in CD1d–/–LDLR–/– mice were 47% smaller at 4 weeks than CD1d+/+LDLR–/– controls; however, there were no differences in lesion size between CD1d–/–LDLR–/– and CD1d+/+LDLR–/– mice at 8 or 12 weeks. We found that although NKT cells were present in the aortic arch of CD1d+/+LDLR–/– mice on the Western diet, no differences in mRNA abundance for Th1 or Th2 cytokines were observed between CD1d–/–LDLR–/– and CD1d+/+LDLR–/– mice.
Conclusions— CD1d-restricted NKT cells contribute to the formation of fatty streaks; however, their influence on lesion progression is transient, and they do not significantly affect the inflammatory cytokine milieu of mature lesions.
Mice deficient in CD1d-restricted natural killer T cells have reduced atherosclerosis only during the earliest stages of fatty streak formation, indicating that the contribution of natural killer T cells to lesion formation is transient.
Key Words: atherosclerosis • cardiovascular diseases • inflammation • lipoproteins • lymphocytes
This article has been cited by other articles:
 |
|
 |
|
  L. Rogers, S. Burchat, J. Gage, M. Hasu, M. Thabet, L. Wilcox, T. A. Ramsamy, and S. C. Whitman Deficiency of invariant V{alpha}14 natural killer T cells decreases atherosclerosis in LDL receptor null mice Cardiovasc Res, April 1, 2008; 78(1): 167 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Strom, M. Wigren, A. Hultgardh-Nilsson, A. Saxena, M. F. Gomez, S. Cardell, G. N. Fredrikson, and J. Nilsson Involvement of the CD1d Natural Killer T Cell Pathway in Neointima Formation After Vascular Injury Circ. Res., October 12, 2007; 101(8): e83 - e89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. VanderLaan, C. A. Reardon, Y. Sagiv, L. Blachowicz, J. Lukens, M. Nissenbaum, C.-R. Wang, and G. S. Getz Characterization of the Natural Killer T-Cell Response in an Adoptive Transfer Model of Atherosclerosis Am. J. Pathol., March 1, 2007; 170(3): 1100 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Aslanian and I. F. Charo Targeted Disruption of the Scavenger Receptor and Chemokine CXCL16 Accelerates Atherosclerosis Circulation, August 8, 2006; 114(6): 583 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Harvey and D. P. Ramji Interferon-{gamma} and atherosclerosis: Pro- or anti-atherogenic? Cardiovasc Res, July 1, 2005; 67(1): 11 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. VanderLaan and C. A. Reardon Thematic review series: The Immune System and Atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis J. Lipid Res., May 1, 2005; 46(5): 829 - 838. [Abstract] [Full Text] [PDF]
|
|